GXEA:FRA
Lakefront Biotherapeutics NV - ADR
€26.40
0.00%
(0.00) 1D
Oct 13, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GXEA...
Open
€26.40
High
€26.40
Low
€26.40
Mkt. cap
1.74B
Avg. vol.
17.00
Volume
0.00
52-wk high
€29.40
52-wk low
€22.40
No. of employees
196
Open
€26.40
High
€26.40
Low
€26.40
Mkt. cap
1.74B
Avg. vol.
17.00
Volume
0.00
52-wk high
€29.40
52-wk low
€22.40
No. of employees
196
News stories
From web sources and news partners
Stock Titan
·
56 minutes ago
A one-year monitor leaves CN Healthy Food Tech (Nasdaq: UCFI) no cure period if listing standards lapse.
The Globe and Mail
·
36 minutes ago
Kaplan Fox Urges AST SpaceMobile, Inc. (NASDAQ: ASTS) Investors to Contact the Firm Before the Deadline on November 13, 2026
24/7 Wall St.
·
9 minutes ago
These 3 International Dividend ETFs Outyield SCHD and Are Beating the S&P 500 Over the Past Year
Seeking Alpha
·
2 hours ago
Three things to look out for on Wednesday
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV - ADR
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorBiotechnology
Websitelakefrontbio.com